CTNNBL1 restricts HIV-1 replication by suppressing viral DNA integration into the cell genome
Tài liệu tham khảo
Baldauf, 2012, SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells, Nat. Med., 18, 1682, 10.1038/nm.2964
Barr, 2008, The interferon response inhibits HIV particle production by induction of TRIM22, PLoS Pathog., 4, e1000007, 10.1371/journal.ppat.1000007
Brainard, 2011, Clinical pharmacology profile of raltegravir, an HIV-1 integrase strand transfer inhibitor, J. Clin. Pharmacol., 51, 1376, 10.1177/0091270010387428
Brown, 1989, Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein, Proc. Natl. Acad. Sci. U S A, 86, 2525, 10.1073/pnas.86.8.2525
Butler, 2001, A quantitative assay for HIV DNA integration in vivo, Nat. Med., 7, 631, 10.1038/87979
Chan, 2012, Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor, Hum. Gene Ther., 23, 1176, 10.1089/hum.2012.083
Chandra, 2013, Deficiency in spliceosome-associated factor CTNNBL1 does not affect ongoing cell cycling but delays exit from quiescence and results in embryonic lethality in mice, Cell Cycle, 12, 732, 10.4161/cc.23594
Cherepanov, 2003, HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells, J. Biol. Chem., 278, 372, 10.1074/jbc.M209278200
Cherepanov, 1999, Activity of recombinant HIV-1 integrase on mini-HIV DNA, Nucleic Acids Res., 27, 2202, 10.1093/nar/27.10.2202
Craigie, 2014, Host factors in retroviral integration and the selection of integration target sites, Microbiol. Spectr., 2, 10.1128/microbiolspec.MDNA3-0026-2014
Debyser, 2015, Host factors for retroviral integration site selection, Trends Biochem. Sci., 40, 108, 10.1016/j.tibs.2014.12.001
Engelman, 2008, The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication, PLoS Pathog., 4, e1000046, 10.1371/journal.ppat.1000046
Farnet, 1990, Integration of human immunodeficiency virus type 1 DNA in vitro, Proc. Natl. Acad. Sci. U S A, 87, 4164, 10.1073/pnas.87.11.4164
Foster, 2016, Resistance of transmitted founder HIV-1 to IFITM-mediated restriction, Cell Host Microbe, 20, 429, 10.1016/j.chom.2016.08.006
Friedrich, 2010, Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line, Virol. J., 7, 354, 10.1186/1743-422X-7-354
Ganesh, 2011, CTNNBL1 is a novel nuclear localization sequence-binding protein that recognizes RNA-splicing factors CDC5L and Prp31, J. Biol. Chem., 286, 17091, 10.1074/jbc.M110.208769
Goujon, 2013, Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection, Nature, 24, 559, 10.1038/nature12542
Huang, 2013, The structure of full-length human CTNNBL1 reveals a distinct member of the armadillo-repeat protein family, Acta Crystallogr. D Biol. Crystallogr., 69, 1598, 10.1107/S0907444913011360
Jabbour, 2003, Sequence, gene structure, and expression pattern of CTNNBL1, a minor-class intron-containing gene--evidence for a role in apoptosis, Genomics, 81, 292, 10.1016/S0888-7543(02)00038-1
Kane, 2013, MX2 is an interferon-induced inhibitor of HIV-1 infection, Nature, 502, 563, 10.1038/nature12653
Laguette, 2011, SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx, Nature, 474, 654, 10.1038/nature10117
Lahouassa, 2012, SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates, Nat. Immunol., 13, 223, 10.1038/ni.2236
Li, 2020, TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity, EMBO Rep., 21, e47528, 10.15252/embr.201847528
Liang, 2019, Membrane metalloprotease TRABD2A restricts HIV-1 progeny production in resting CD4(+) T cells by degrading viral Gag polyprotein, Nat. Immunol., 20, 711, 10.1038/s41590-019-0385-2
Liu, 2008, Genome-wide association scans identified CTNNBL1 as a novel gene for obesity, Hum. Mol. Genet., 17, 1803, 10.1093/hmg/ddn072
Llano, 2006, An essential role for LEDGF/p75 in HIV integration, Science, 314, 461, 10.1126/science.1132319
Maertens, 2003, LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells, J. Biol. Chem., 278, 33528, 10.1074/jbc.M303594200
Maldarelli, 2016, The role of HIV integration in viral persistence: no more whistling past the proviral graveyard, J. Clin. Invest., 126, 438, 10.1172/JCI80564
Mashiba, 2014, Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production, Cell Host Microbe, 16, 722, 10.1016/j.chom.2014.10.014
McKee, 2008, Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein, J. Biol. Chem., 283, 31802, 10.1074/jbc.M805843200
Neil, 2008, Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu, Nature, 451, 425, 10.1038/nature06553
O'Doherty, 2000, Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding, J. Virol., 74, 10074, 10.1128/JVI.74.21.10074-10080.2000
O'Doherty, 2002, A sensitive, quantitative assay for human immunodeficiency virus type 1 integration, J. Virol., 76, 10942, 10.1128/JVI.76.21.10942-10950.2002
Rosa, 2015, HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation, Nature, 526, 212, 10.1038/nature15399
Sharma, 2013, BET proteins promote efficient murine leukemia virus integration at transcription start sites, Proc. Natl. Acad. Sci. U S A., 110, 12036, 10.1073/pnas.1307157110
Sheehy, 2002, Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, Nature, 418, 646, 10.1038/nature00939
Soper, 2017, Type I interferon responses by HIV-1 infection: association with disease progression and control, Front. Immunol., 8, 1823, 10.3389/fimmu.2017.01823
Swiggard, 2005, Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli, J. Virol., 79, 14179, 10.1128/JVI.79.22.14179-14188.2005
Usami, 2015, SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef, Nature, 526, 218, 10.1038/nature15400
Van Maele, 2006, Cellular co-factors of HIV-1 integration, Trends Biochem. Sci., 31, 98, 10.1016/j.tibs.2005.12.002
van Maldegem, 2015, CTNNBL1 facilitates the association of CWC15 with CDC5L and is required to maintain the abundance of the Prp19 spliceosomal complex, Nucleic Acids Res., 43, 7058, 10.1093/nar/gkv643
Wang, 2016, M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner, Sci. Rep., 6, 32736, 10.1038/srep32736
Wisniewski, 2009, Universal sample preparation method for proteome analysis, Nat. Methods, 6, 359, 10.1038/nmeth.1322
Zhao, 2018, The Per-1 Short Isoform Inhibits de novo HIV-1 Transcription in Resting CD4+ T-cells, Curr. Hiv Res., 16, 384, 10.2174/1570162X17666190218145048